08.25.25 -- Abalone Bio's FAST Platform: How Does It Differ From Traditional Affinity Screening?

Traditional depth filtration struggles with lentiviral harvest clarification, leading to low yields and high costs. However, single-use centrifugation offers a promising alternative.

Explore how precise cell culture conditions are critical to advancing CAR T-cell therapies, which empowers researchers to develop more effective cancer treatments and accelerate breakthroughs.

Discover how Raman spectroscopy and parallel bioprocessing enable real-time cell culture monitoring, saving time and providing crucial data for process optimization in biopharmaceutical production.

Address the rising gene therapy demands with an innovative perfusion strategy that significantly boosts cell density and viral vector yields to pave the way for scalable, efficient manufacturing.

Learn how innovations in automation and digitalization are transforming CLD, streamlining biologics production, and helping companies overcome challenges in next-generation therapy development.

A strategic approach to cell culture media is essential for success. Learn how to get a head start toward clinical readiness and avoid future hurdles with optimized media.

Learn about a next-generation transfection system that requires 50% less plasmid, decreases transfection reagent consumption, and yields higher AAV productivity to reduce cost per dose.

Technology transfer, the transmission of bioprocess knowledge, skills and technology, is a crucial mechanism for ensuring adequate and timely access to innovative medicines.

Low AAV productivity and lack of platform processes continue to be key challenges driving AAV production cost up. Explore a robust and scalable suspension manufacturing platform for AAV production.

Explore how using a flexible, automated system can help expand induced pluripotent stem cells (iPSCs) faster than traditional culture methods.